Bayer | BAYN - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Air Liquide EUR 125.9M 3.6M 2025-12
Akzo Nobel EUR 68M 26M 2025-06
Alcon AG USD 53M 1000K 2026-06
Amarin USD 3K 5K 2024-12
Arkema EUR 11M 582M 2025-06
AstraZeneca USD 371M 31M 2026-09
BASF EUR 229M 7M 2026-09
Bayer EUR 675M 87M 2025-12
Beiersdorf EUR 14M 6.5M 2026-06
Corteva USD 47M 11M 2026-06
Covestro EUR 33M 1000K 2025-09
Essilor EUR 188M 20M 2026-06
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 97.5M 14.5M 2026-09
Genmab DKK 139M 129M 2026-06
Givaudan CHF 58M 7M 2025-12
GlaxoSmithKline GBP 219M 98M 2026-09
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Johnson Matthey GBP 75M 4M 2024-06
Linde USD 71M 7M 2026-09
Lonza CHF 84M 14M 2025-06
Merck EUR 137M 33M 2026-06
Novartis USD 468M 6M 2026-09
Nutrien USD 178M 5M 2026-09
Philips EUR 84M 1000K 2026-09
PPG Industries USD 67M 4M 2026-09
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 222M 65M 2026-09
SAP EUR 287M 36M 2026-09
Solvay EUR 24M 1000K 2026-06
UCB EUR 49M 29M 2025-12
Umicore EUR 36.5M 33.15M 2024-12
Vinci EUR 798M 35M 2026-06